Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Darras

Showing results (211-220 of 303) with videos related to

Pageof 31
Sort By:
Journal of Clinical Medicine|May 11, 2024
Beyond Contractures in Spinal Muscular Atrophy: Identifying Lower-Limb Joint HypermobilityElizabeth R Harding, Cara H Kanner, Amy Pasternak, et al.
The New England Journal of Medicine|February 24, 2021
Risdiplam in Type 1 Spinal Muscular AtrophyGiovanni Baranello, Basil T Darras, John W Day, et al.
Pediatric Neurology|May 31, 2022
Nusinersen for Patients With Spinal Muscular Atrophy: 1415 Doses via an Interdisciplinary Institutional ApproachElena Madan, Sabrina Carrié, Carolina Donado, et al.
Neurology|March 10, 2010
Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophyJ Montes, M P McDermott, W B Martens, et al.
The New England Journal of Medicine|July 28, 2021
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical ControlsBasil T Darras, Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, et al.
Muscle & Nerve|July 13, 2019
Nusinersen improves walking distance and reduces fatigue in later-onset spinal muscular atrophyJacqueline Montes, Sally Dunaway Young, Elena S Mazzone, et al.
Journal of Child Neurology|September 24, 2011
Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and IIIAllan M Glanzman, Jessica M O'Hagen, Michael P McDermott, et al.
Neuromuscular Disorders : NMD|July 31, 2007
An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patientsJessica M O'Hagen, Allan M Glanzman, Michael P McDermott, et al.
Pediatric Neurology|May 21, 2014
One year outcome of boys with Duchenne muscular dystrophy using the Bayley-III scales of infant and toddler developmentAnne M Connolly, Julaine M Florence, Mary M Cradock, et al.
Neuromuscular Disorders : NMD|September 7, 2020
Gain and loss of abilities in type II SMA: A 12-month natural history studyGiorgia Coratti, Simona Lucibello, Maria C Pera, et al.
Pageof 31

Showing results (211-220 of 303) with videos related to

Sort By:
Pageof 31
Journal of Clinical Medicine|May 11, 2024
Beyond Contractures in Spinal Muscular Atrophy: Identifying Lower-Limb Joint HypermobilityElizabeth R Harding, Cara H Kanner, Amy Pasternak, et al.
The New England Journal of Medicine|February 24, 2021
Risdiplam in Type 1 Spinal Muscular AtrophyGiovanni Baranello, Basil T Darras, John W Day, et al.
Pediatric Neurology|May 31, 2022
Nusinersen for Patients With Spinal Muscular Atrophy: 1415 Doses via an Interdisciplinary Institutional ApproachElena Madan, Sabrina Carrié, Carolina Donado, et al.
Neurology|March 10, 2010
Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophyJ Montes, M P McDermott, W B Martens, et al.
The New England Journal of Medicine|July 28, 2021
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical ControlsBasil T Darras, Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, et al.
Muscle & Nerve|July 13, 2019
Nusinersen improves walking distance and reduces fatigue in later-onset spinal muscular atrophyJacqueline Montes, Sally Dunaway Young, Elena S Mazzone, et al.
Journal of Child Neurology|September 24, 2011
Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and IIIAllan M Glanzman, Jessica M O'Hagen, Michael P McDermott, et al.
Neuromuscular Disorders : NMD|July 31, 2007
An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patientsJessica M O'Hagen, Allan M Glanzman, Michael P McDermott, et al.
Pediatric Neurology|May 21, 2014
One year outcome of boys with Duchenne muscular dystrophy using the Bayley-III scales of infant and toddler developmentAnne M Connolly, Julaine M Florence, Mary M Cradock, et al.
Neuromuscular Disorders : NMD|September 7, 2020
Gain and loss of abilities in type II SMA: A 12-month natural history studyGiorgia Coratti, Simona Lucibello, Maria C Pera, et al.
Pageof 31